Clinical trial
An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly…
NCT00319709 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00319709 |
|---|---|
| Title | An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With Depression |
| Official title | An Eight-Week, Double-Blind Placebo Controlled, Multicenter Study Evaluating the Efficacy, Safety, Tolerability of a Fixed Dose of SR58611A (350 mg q12) in Elderly Patients With Major Depressive Disorder (MDD) |
| Acronym | ZEPHIR |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Depressive Disorder |
| Intervention type | Drug |
| Interventions | SR58611A |
| Enrollment | 288 |
| Start date | Apr 1, 2006 |
| Primary completion | Apr 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Apr 27, 2006 |
| Last update posted | Mar 12, 2009 |
| Countries | Bulgaria, Finland, Romania, Serbia, Slovakia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: